CS 8958: Clinical Trials

1 trial of CS 8958, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow CS 8958: new trials by email Literature Review of CS 8958 trials Research Report on CS 8958

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate - Influenza
Phase 1 / Phase 2TerminatedBiota Scientific Management Pty Ltd152013-11-012025-01-13

Conditions studied

Influenza, Human (1)

Sponsors

Biota Scientific Management Pty Ltd (1)

Countries

United States (1)

Top investigators

Jolanta Airey, Dr (1)